China: Four new crown vaccines are in clinical trials

The study confirmed that the new crown inactivated vaccine developed by Beijing Kexing Zhongwei Biotechnology is safe and effective in the rhesus monkey model. This is the first publicly reported animal experimental study of the new crown vaccine. The Phase I / II clinical study was launched on April 16 in Suining County, Xuzhou City, Jiangsu Province.
On April 12, an innovative recombinant vaccine product led by Academician Chen Wei of the Chinese Academy of Military Sciences led the development of a recombinant new coronavirus (adenoviral vector) vaccine in Wuhan. The subject's vaccination test officially began in Wuhan, which means that the world's first new coronavirus vaccine entered II Phase clinical trials.
The two new crown inactivated vaccines approved by Sinopharm China Biotech in clinical trials are the new crown inactivated vaccines obtained by the world's first clinical trial approval, and are jointly researched by China National Pharmaceutical Group Wuhan Biological Products Research Institute and Wuhan Institute of Virology, Chinese Academy of Sciences, and On April 28, the Phase I / II clinical trial was launched, a new crown inactivated vaccine jointly developed by Sinopharm Group China Bio Beijing Institute of Biological Products and the Chinese Center for Disease Control and Prevention Viral Disease Prevention and Control.
When can I use the new crown vaccine? Gao Fu, director of the Chinese Center for Disease Control and Prevention, said in an interview with China International Television on April 23 that China is at the forefront of research and development of new crown vaccines, and there may be emergency use of new crown vaccines in September.